The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sodium citrate dihydrate · TRISODIUM CITRATE DIHYDRATE 230 mg/1 · Tablet, Chewable · Oral · Walgreens Co.
NDC 00363-1834-42 · 1 BOTTLE in 1 BOX / 42 TABLET, CHEWABLE in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| WellSpring Pharmaceutical Corporation | TRISODIUM CITRATE DIHYDRATE 230 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Cvs Pharmacy,inc. | TRISODIUM CITRATE DIHYDRATE 230 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Quality Choice (Chain Drug Marketing Association) | TRISODIUM CITRATE DIHYDRATE 230 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Walgreens Co. | TRISODIUM CITRATE DIHYDRATE 230 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "WALGREENS UPSET STOMACH and NAUSEA RELIEF — NDC 00363-1834-42," retrieved September 3, 2026, https://drugdashboards.com/drug/00363183442.
Free to cite with attribution — see how the data is put together.